US Patent 8008504 Process for the synthesis of organic compounds
Patent 8008504 was granted and assigned to Novartis on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+267 characters)
Article
Patent abstract
The present invention provides an efficient, safe and cost effective way to prepare 5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine which is a key intermediate for the preparation of substituted pyrimidinylaminobenzamides of formula (II):
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08008504 Process for the synthesis of organic compounds US Patent 8008504 Process for the synthesis of organic compounds
Infobox
Patent Number
0800850400
Patent Number
800850400
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080085040
Date of Patent
August 30, 2011
0Patent Application Number
128342950
Date Filed
July 12, 2010
0Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080085040
Date of Patent
August 30, 2011
0Patent Application Number
128342950
Date Filed
July 12, 2010
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08008504 Process for the synthesis of organic compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08008504
Date of patent
August 30, 2011
Patent application number
12834295
Date Filed
July 12, 2010
Patent primary examiner
Find more entities like US Patent 8008504 Process for the synthesis of organic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
